litlas
Log inCreate account

Federico Mingozzi

Active 2001–2025

109
Papers
25,079
Citations
74
h-index
106
i10-index

Citations

Citations per year for Federico Mingozzi1984: 1 citations1997: 1 citations1999: 1 citations2001: 1 citations2002: 6 citations2003: 7 citations2004: 21 citations2005: 20 citations2006: 57 citations2007: 78 citations2008: 126 citations2009: 167 citations2010: 161 citations2011: 188 citations2012: 202 citations2013: 322 citations2014: 296 citations2015: 272 citations2016: 216 citations2017: 477 citations2018: 312 citations2019: 1,033 citations2020: 1,330 citations2021: 1,229 citations2022: 1,083 citations2023: 985 citations2024: 1,136 citations2025: 720 citations2026: 8 citations1985–1996: no citations, so these years are not shown1998: no citations, so this year is not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,463 citing papers, 36% of this breakdownUnited Kingdom: 518 citing papers, 7.6% of this breakdownChina: 508 citing papers, 7.4% of this breakdownFrance: 377 citing papers, 5.5% of this breakdownGermany: 375 citing papers, 5.5% of this breakdownItaly: 323 citing papers, 4.7% of this breakdownCanada: 213 citing papers, 3.1% of this breakdownNetherlands: 209 citing papers, 3% of this breakdownSpain: 175 citing papers, 2.6% of this breakdownAustralia: 169 citing papers, 2.5% of this breakdownJapan: 152 citing papers, 2.2% of this breakdownSwitzerland: 131 citing papers, 1.9% of this breakdown
0%36%Other 18%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology68.8%
  • Medicine22.7%
  • Neuroscience4.6%
  • Immunology and Microbiology2.2%
  • Engineering0.7%
  • Materials Science0.4%
  • Other0.6%

Topics

  • Virus-based gene therapy research15.8%
  • CRISPR and Genetic Engineering8.8%
  • RNA Interference and Gene Delivery7.1%
  • Retinal Development and Disorders5.3%
  • CAR-T cell therapy research4.2%
  • Viral Infectious Diseases and Gene Expression in Insects3.4%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Authors: Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda, Bertil Glader, Margaret V. Ragni, John E.J. Rasko, Margareth C. Ozelo, Keith Hoots, Philip M. Blatt, Barbara A. Konkle, Michael D. Dake, Robin Kaye, Mahmood Razavi, Albert Zajko, James L. Zehnder, Pradip K. Rustagi, Hiroyuki Nakai, Amy Chew, Debra G. B. Leonard, J Fraser Wright, Ruth Lessard, Jürg M. Sommer, Michael Tigges, Denise E. Sabatino, Alvin Luk, Haiyan Jiang, Federico Mingozzi, Linda Couto, Hildegund C.J. Ertl, Katherine A. High, Mark A. Kay - Nature Medicine 2006 cited by 2,135

  2. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

    Authors: Helena Costa Verdera, Klaudia Kuranda, Federico Mingozzi - Molecular Therapy 2020 cited by 627

  3. Emerging Issues in AAV-Mediated In Vivo Gene Therapy

    Authors: Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi - Molecular Therapy — Methods & Clinical Development 2017 cited by 864

  4. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Authors: Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Pie, Chris F. Harrington, James O’Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip K. Rustagi, Catherine Y. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James A. Allay, John B. Coleman, Susan Sleep, John M. Cunningham, Deo Kumar Srivastava, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, John T. Gray, Ulrike M. Reiss, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2011 cited by 1,843

  5. Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

    Authors: Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lhériteau, Nishal Patel, Deepak B. Thimiri Govinda Raj, Anne Riddell, Jun Pie, Savita Rangarajan, David Bevan, Michael Recht, Yu‐Min Shen, Kathleen G. Halka, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, James A. Allay, Mark A. Kay, Catherine Y. Ng, Junfang Zhou, Maria Cancio, Christopher L. Morton, John T. Gray, Deo Kumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2014 cited by 1,250

  6. Immune responses to AAV vectors: overcoming barriers to successful gene therapy

    Authors: Federico Mingozzi, Katherine A. High - Blood 2013 cited by 920

  7. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies

    Authors: Christian Leborgne, Elena Barbon, J M Alexander, Hayley A. Hanby, Sandrine Delignat, Daniel M. Cohen, Fanny Collaud, Saghana Muraleetharan, Dan Lupo, Joseph Silverberg, Karen Huang, Laetitia van Wittengerghe, Béatrice Marolleau, Adeline Miranda, Anna Fabiano, Victoria Daventure, Heena Beck, Xavier M. Anguela, Giuseppe Ronzitti, Sean M. Armour, Sébastien Lacroix‐Desmazes, Federico Mingozzi - Nature Medicine 2020 cited by 319

  8. Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    Authors: Albert M. Maguire, Francesca Simonelli, Eric A. Pierce, Edward N. Pugh, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen Marshall, Francesco Testa, Enrico Maria Surace, Settimio Rossi, Arkady Lyubarsky, Valder R. Arruda, Barbara A. Konkle, Edwin M. Stone, Junwei Sun, Jonathan B. Jacobs, Lou F Dell'Osso, Richard W. Hertle, Jian‐xing Ma, T. Michael Redmond, Xiaosong Zhu, Bernd Hauck, Olga Zelenaia, Kenneth S. Shindler, Maureen G. Maguire, J. Fraser Wright, Nicholas J. Volpe, Jennifer Wellman McDonnell, Alberto Auricchio, Katherine A. High, Jean Bennett - New England Journal of Medicine 2008 cited by 2,137

  9. CD8+ T-cell responses to adeno-associated virus capsid in humans

    Authors: Federico Mingozzi, Marcela V. Maus, Daniel J. Hui, Denise E. Sabatino, Samuel L. Murphy, John E.J. Rasko, Margaret V. Ragni, Catherine S. Manno, Jürg M. Sommer, Haiyan Jiang, Glenn F. Pierce, Hildegund C.J. Ertl, Katherine A. High - Nature Medicine 2007 cited by 726

  10. Human Immune Responses to Adeno-Associated Virus (AAV) Vectors

    Authors: Giuseppe Ronzitti, David‐Alexandre Gross, Federico Mingozzi - Frontiers in Immunology 2020 cited by 344

  11. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

    Authors: Lindsey A. George, Paul E. Monahan, M. Elaine Eyster, Spencer K. Sullivan, Margaret V. Ragni, Stacy E. Croteau, John E.J. Rasko, Michael Recht, Benjamin J. Samelson‐Jones, Amy MacDougall, Kristen Jaworski, Robert Noble, Marla Curran, Klaudia Kuranda, Federico Mingozzi, Tiffany Chang, Kathleen Z. Reape, Xavier M. Anguela, Katherine A. High - New England Journal of Medicine 2021 cited by 253

  12. Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses

    Authors: Ying Chan, Sean K. Wang, Colin J. Chu, David A. Copland, Alexander J. Letizia, Helena Costa Verdera, Jessica J. Chiang, Meher Sethi, May K. Wang, William J. Neidermyer, Yingleong Chan, Elaine T. Lim, Amanda Graveline, Melinda Sanchez, Ryan F. Boyd, Thomas S. Vihtelic, Rolando Gian Carlo O. Inciong, Jared M. Slain, Priscilla J. Alphonse, Yunlu Xue, Lindsey R. Robinson‐McCarthy, Jenny M. Tam, Maha Jabbar, Bhubanananda Sahu, Janelle Fassbender Adeniran, Manish Muhuri, Phillip W.L. Tai, Jun Xie, Tyler B. Krause, Andyna Vernet, Matthew J. Pezone, Ru Xiao, Tina Liu, Wei Wang, Henry J. Kaplan, Guangping Gao, Andrew D. Dick, Federico Mingozzi, Maureen A. McCall, Constance L. Cepko, George M. Church - Science Translational Medicine 2021 cited by 207

  13. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

    Authors: Amine Meliani, Florence Boisgérault, Romain Hardet, Solenne Marmier, Fanny Collaud, Giuseppe Ronzitti, Christian Leborgne, Helena Costa Verdera, Marcelo Simon Sola, Séverine Charles, Alban Vignaud, Laetitia van Wittenberghe, Giorgia Manni, Olivier D. Christophe, Francesca Fallarino, Christopher Roy, Alicia Michaud, Petr O. Ilyinskii, Takashi Kishimoto, Federico Mingozzi - Nature Communications 2018 cited by 254

  14. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B

    Authors: Lindsey A. George, Margaret V. Ragni, John E.J. Rasko, Leslie Raffini, Benjamin J. Samelson‐Jones, Margareth C. Ozelo, Maria Hazbon, Alexa R. Runowski, Jennifer Wellman, Katie Wachtel, Yifeng Chen, Xavier M. Anguela, Klaudia Kuranda, Federico Mingozzi, Katherine A. High - Molecular Therapy 2020 cited by 209

  15. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    Authors: Albert M. Maguire, Katherine A. High, Alberto Auricchio, J. Fraser Wright, Eric A. Pierce, Francesco Testa, Federico Mingozzi, Jeannette Bennicelli, Gui‐Shuang Ying, Settimio Rossi, Ann Fulton, Kathleen Marshall, Sandro Banfi, Daniel C. Chung, Jessica I. W. Morgan, Bernd Hauck, Olga Zelenaia, Xiaosong Zhu, Leslie Raffini, Frauke Coppieters, Elfride De Baere, Kenneth S. Shindler, Nicholas J. Volpe, Enrico Maria Surace, Carmela Acerra, Arkady Lyubarsky, T. Michael Redmond, Edwin M. Stone, Junwei Sun, Jennifer Wellman McDonnell, Bart P. Leroy, Francesca Simonelli, Jean Bennett - The Lancet 2009 cited by 858

  16. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

    Authors: Federico Mingozzi, Katherine A. High - Nature Reviews Genetics 2011 cited by 901

  17. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    Authors: Jean Bennett, Jennifer Wellman, Kathleen Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano‐Pappas, Okan U. Elci, Daniel C. Chung, Junwei Sun, J. Fraser Wright, Dominique Cross, Puya Aravand, Laura Cyckowski, Jeannette Bennicelli, Federico Mingozzi, Alberto Auricchio, Eric A. Pierce, Jason Ruggiero, Bart P. Leroy, Francesca Simonelli, Katherine A. High, Albert M. Maguire - The Lancet 2016 cited by 456

  18. Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood

    Authors: Corinne J. Smith, Nikki L. Ross, Ali Kamal, Kevin Y. Kim, Elizabeth Kropf, Pascal Deschatelets, Cedric Francois, William J. Quinn, Inderpal Singh, Anna Majowicz, Federico Mingozzi, Klaudia Kuranda - Frontiers in Immunology 2022 cited by 81

  19. Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

    Authors: Federico Mingozzi, Xavier M. Anguela, Giulia Pavani, Yifeng Chen, Robert J. Davidson, Daniel J. Hui, Mustafa N. Yazicioglu, Liron Elkouby, Christian Hinderer, Armida Faella, Carolann Howard, Alex Tai, Gregory M. Podsakoff, Shangzhen Zhou, Etiena Basner‐Tschakarjan, J. Fraser Wright, Katherine A. High - Science Translational Medicine 2013 cited by 344

  20. Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction

    Authors: Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, Laetitia van Wittenberghe, Alban Vignaud, Fanny Collaud, Séverine Charles, Marcelo Simon Sola, F. Jouen, Olivier Boyer, Federico Mingozzi - Molecular Therapy — Methods & Clinical Development 2018 cited by 197

  21. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy

    Authors: Haiyan Jiang, Linda B. Couto, Susannah Patarroyo‐White, Tongyao Liu, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jürg M. Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce - Blood 2006 cited by 320

  22. AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells

    Authors: Federico Mingozzi, J. J. M. Meulenberg, Daniel J. Hui, Etiena Basner‐Tschakarjan, Nicole C. Hasbrouck, Shyrie Edmonson, Natalie A. Hutnick, Michael R. Betts, John J.P. Kastelein, Erik S.G. Stroes, Katherine A. High - Blood 2009 cited by 284

  23. Assessing the potential for AAV vector genotoxicity in a murine model

    Authors: Hojun Li, Nirav Malani, Shari R Hamilton, Alexander Schlachterman, Giulio Bussadori, Shyrie E. Edmonson, Rachel Shah, Valder R. Arruda, Federico Mingozzi, J. Fraser Wright, Frederic D. Bushman, Katherine A. High - Blood 2010 cited by 228

  24. Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial

    Authors: Céline Vandamme, Oumeya Adjali, Federico Mingozzi - Human Gene Therapy 2017 cited by 219